12/05/2016
https://congress.gov...
"These problems will likely extend to the development and distribution of a COVID-19 vaccine, as long as Trump is President."
"This committee has a responsibility--to conduct oversight of those congressional investments."
"Hon. Diana DeGette, a Representative in Congress from the State of Colorado, opening statement."
"This transparency will be crucial to securing the American people's trust that a COVID-19 vaccine will be made available only once it's proven to be safe and effective."